Skip to main content
Fig. 6 | BMC Endocrine Disorders

Fig. 6

From: The differences between insulin glargine U300 and insulin degludec U100 in impact on the glycaemic variability, arterial stiffness and the lipid profiles in insulin naïve patients suffering from type two diabetes mellitus – outcomes from cross‐over open-label randomized trial

Fig. 6

Changes in plasma lipids. The only statistically significant difference between two insulins was in the impact on LDL. TG = triglycerides, CH = total cholesterol, HDL = high density protein, LDL = low density protein, IGlar-300 = insulin glargine U300, IDeg-100 = insulin degludec U100. The results are depicted as derivations of absolute values and represented as percentage of change.

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us